Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.

We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Alnylam Pharmaceuticals, ...

Akero Therapeutics Inc. (NASDAQ: AKRO) is one of the best mid cap pharma stocks to buy. On July 16, AstraZeneca announced ...

Topline data were announced from a phase 3 clinical program evaluating anselamimab in patients with Mayo stages 3a and 3b light chain (AL) amyloidosis.

A routine, low-cost heart test may be on the verge of a transformative upgrade thanks to artificial intelligence. With ...

One chemistry tweak made mRNA vaccines dramatically safer and more effective—unlocking new potential for fighting disease.

Blue-chip stocks are shares of large, well-established, financially stable companies with a consistent and reliable ...

This month: good news for java lovers, a how-to guide on migraine and CVD, medically tailored meals for HF, and more.

The phase 3 trial randomized 260 people with anti-acetylcholine receptor antibody-positive gMG to take gefurulimab or placebo. After 26 weeks, people on gefurulimab performed significantly better on a ...

Multiple myeloma is predominantly a disease of the elderly, with the median age at diagnosis about 70; one-third of patients ...

Learn how ATTR-CM is treated with medications that slow down the condition's progression and other therapies that reduce ...